Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meliora Therapeutics
Menlo Park, California, United Statesmelioratherapeutics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Meliora Therapeutics has developed a proprietary computational platform that uses machine learning to identify the true mechanisms-of-action for small molecule oncology drugs. The company aims to improve success rates in oncology drug development by building an atlas of drug mechanisms and developing new therapies based on these insights. As of early 2025, the company has raised $11M in seed funding and advanced multiple preclinical programs but has not yet reported clinical trial results.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules
- Industry
- Biotech
Beyond the preview
Go deeper on Meliora Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Meliora Therapeutics.